AI HEALTH TECH (01715) announced its interim results for the six months ended June 30, 2025, reporting revenue of RMB 23.94 million, down 57.21% year-on-year; loss attributable to shareholders of RMB 11.5 million, narrowing 50.32% year-on-year; and basic loss per share of RMB 0.08.